Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 987 | 958 | 987 | 627 | 1013 | 3038 |
Fund Return | -1.34% | -4.21% | -1.34% | -14.42% | 0.25% | 11.75% |
Place in category | 497 | 519 | 497 | 337 | 243 | 3 |
% in Category | 85 | 78 | 85 | 80 | 87 | 4 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Harvest Value Selected Equity Fund | 4.83B | 12.04 | -1.91 | - | ||
Harvest U.S. Growth Equity QDII RMB | 4.1B | 32.68 | 13.41 | 15.16 | ||
Harvest Taihe Balanced Fd | 3.09B | 0.07 | -13.81 | 10.08 | ||
Harvest Smart Car Eq | 2.78B | -2.08 | -22.52 | - | ||
Harvest SHS Select Equity Fd | 2.76B | 20.75 | -0.29 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Zhong Ou Modern Pioneer InitiatingA | 13.27B | 4.20 | -12.45 | - | ||
TianHong ChiNext Index A | 9.62B | 13.08 | -12.38 | - | ||
TianHong ChiNext Index C | 9.62B | 12.85 | -12.56 | - | ||
ICBC Credit Literary Ids Eq | 5.94B | 17.16 | -7.22 | - | ||
RT SZSE 100 Index Fund A\B | 4.7B | 12.31 | -10.75 | 3.12 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Dong-E E-Jiao A | CNE0000006Y9 | 9.27 | 60.66 | -1.99% | |
Centre Testing Intl Shenzhen | CNE100000GV8 | 6.87 | 12.37 | -0.96% | |
APT Medical | CNE100004C45 | 6.42 | 368.18 | +0.39% | |
Shenzhen Mindray Bio-Medical | CNE100003G67 | 6.40 | 230.36 | -2.13% | |
Shandong Sinocera Func Material | CNE100001FB0 | 5.84 | 17.11 | -0.70% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | BUY | Sell |
Summary | Strong Buy | Buy | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review